Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: The Bogalusa heart study

Diabetes Care

Volumn 34, Issue 12, 2011, Pages 2603-2607

  Nguyen, Quoc Manh ^a   Srinivasan, Sathanur R ^a   Xu, J I Hua ^a   Chen, Wei ^a   Hassig, Susan ^b   Rice, Janet ^c   Berenson, Gerald S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

^b TULANE UNIVERSITY   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; ENZYMOLOGY; FATTY LIVER; FEMALE; LIVER; LIVER DISEASE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE; UNITED STATES;

ADIPOSITY; ADULT; ALANINE TRANSAMINASE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER DISEASES; LONGITUDINAL STUDIES; LOUISIANA; MALE; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84862211891     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0919     Document Type: Article

References (25)

1. Hoyert DL, Heron MP, Murphy SL, Kung H. Deaths: final data for 2003. National Vital Statistics Reports, Vol. 54, No. 13. Hyattsville,MD, National Center for Health Statistics, 2006
2. Naser KA, Gruber A, Thomson GA. The emerging pandemic of obesity and diabetes: are we doing enough to prevent a disaster? Int J Clin Pract 2006;60:1093-1097 (Pubitemid 44226748)
3. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294
4. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-1350
5. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2007;56:792-798 (Pubitemid 46745298)
6. Nannipieri M, Gonzales C, Baldi S, et al.; Mexico City Diabetes Study. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City Diabetes Study. Diabetes Care 2005;28:1757-1762 (Pubitemid 40923089)
7. Sattar N, Scherbakova O, Ford I, et al.;West of Scotland Coronary Prevention Study. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 2004;53:2855-2860 (Pubitemid 39425910)
8. Cho NH, Jang HC, Choi SH, et al. Abnormal liver function test predicts type 2 diabetes: a community-based prospective study. Diabetes Care 2007;30:2566-2568 (Pubitemid 47547795)
9. Mainous AG 3rd, Diaz VA, King DE, Everett CJ, Player MS. The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes. J Am Board Fam Med 2008;21:497-503
10. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F; Group Study D.E.S.I.R. Nineyear incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 2010;10:56
11. Lee DH, Jacobs DR Jr, Gross M, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-1366 (Pubitemid 36900623)
12. The Bogalusa Heart Study 20th anniversary symposium. Am J Med Sci 1995;310 (Suppl. 1):S1-S138
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
14. Berenson GS, McMahan CA, Voors AW, et al. Cardiovascular Risk Factors in Children: The Early Natural History of Atherosclerosis and Essential Hypertension. New York, NY, Oxford University Press, 1980
15. Srinivasan SR, Berenson GS. Serum lipoproteins in children and methods for study. In Handbook of Electrophoresis. Lewis LA, Ed. Boca Raton, FL, CRC Press, 1983, p. 185-204
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419 (Pubitemid 15018832)
17. Nóvoa FJ, Boronat M, Saavedra P, et al. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study. Diabetes Care 2005;28:2388-2393 (Pubitemid 41384282)
18. Nguyen QM, Srinivasan SR,Xu JH, Chen W, Berenson GS. Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study. Diabetes Care 2008;31:2044-2049
19. Srinivasan SR, Myers L, Berenson GS. Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study. Metabolism 1999;48:928-934 (Pubitemid 29310052)
20. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 2002;51:204-209 (Pubitemid 34517999)
21. Weiss R, Dufour S, Taksali SE, et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003;362:951-957 (Pubitemid 37159290)
22. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 1995;19:846-850 (Pubitemid 26003019)
23. Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE. Diabetes and apoptosis: lipotoxicity. Apoptosis 2009;14:1484-1495
24. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003;52:1779-1785 (Pubitemid 36792470)
25. Weltman MD, Farrell GC,Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128-133 (Pubitemid 28041545)